SCHEMBL4901065

SCHEMBL4901065

CCNC(=O)c1cc(F)ccc1Cc1cnc2c(OC(=O)c3ccccc3)c(C(=O)OCC)c(=O)n(C)c2c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 2/20 0.36
ALOX15 P16050 1/20 0.36
KDM4E B2RXH2 1/20 0.36
THRB P10828 1/20 0.35
PAX8 Q06710 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
TSHR P16473 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
S1PR3 Q99500 3/20 0.33
MAPT P10636 2/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.33
PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906748 0.94 ALDH1A1 (0.36) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL4894963 0.92 ALDH1A1 (0.34) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL4909515 0.92 ALDH1A1 (0.37) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL4898503 0.91 THRB (0.37) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL4904368 0.89 THRB (0.35) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL14067449 0.89 ALDH1A1 (0.38) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL14067482 0.89 ALDH1A1 (0.38) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL4903178 0.89 ALDH1A1 (0.35) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL4904278 0.88 THRB (0.35) ALDH1A1NPC1ALOX15KDM4ETHRB
SCHEMBL16021064 0.88 TSHR (0.38) ALDH1A1NPC1ALOX15KDM4ETHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214527-A1 Hiv Integrase Inhibitors SHIONOGI & CO. LTD (JP) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214527-A1 Hiv Integrase Inhibitors API5, ING2, SAMHD1 ALDH1A1 2874/4885NPC1 420/4885ALOX15 3939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.